Virtual Event | May 4, 2023

Building An In-House Cell & Gene Manufacturing Facility: Best Practices & Lessons Learned

The recent market downturn has most certainly impacted cell and gene therapy's build versus buy debate. Yet, with flexible and sustainable design strategies and best practices and contingency planning based on current market conditions and exit strategies, building an in-house facility is feasible.

Cell & Gene Live's Erin Harris hosted a panel of subject matter experts who shared their experiences in building state-of-the-art manufacturing facilities and offered detailed advice on how your company may do the same. Available on-demand thanks to the support of Entegris.

access the Virtual Event!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Cell & Gene